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Abstract Extra-intestinal pathogenic Escherichia coli are a
significant cause of urinary tract infection and bacteraemia
within the UK. We sought to identify the serogroups of 658
E. coli isolates collected in the UK between January 2011 and
March 2012, to better understand the ExPEC population and
understand the relevance of serogroups in this pathotype.
Isolates were typed and serogroup identified using established
phenotypic and molecular methods. Sixty-two serogroups
were identified; 54 among urinary isolates and 35 among
bloodstream isolates. However, serogroups O25, O6, and O2
dominated both infection types. These serogroups were linked
to the major ExPEC STs as follows: ST131-O25, ST73-O6,
ST127-O6, and ST95-O2. The serogroup data from this study
have increased our understanding of the ExPEC population in
the UK, but also highlighted key ST–serogroup relationships
within the major ExPEC clones. These data can be used to
guide vaccine design and in the development of laboratory
diagnostic tests targeting the ExPEC population.
Introduction
Multi-locus sequence typing (ST) and phylogenetic grouping
(phylogroup) have become established methods for typing
extra-intestinal pathogenic Escherichia coli (ExPEC) strains.
In the UK the ST131/B2, ST127/B2, ST95/B2, ST73/B2, and
ST69/D lineages are the most frequently recovered from
bloodstream infections (BSI) and urinary tract infections
(UTI) [1–3]. However, prior to the widespread use of these
molecular methods, serotyping was extensively used to char-
acterise pathogenic E. coli, [4, 5] as well as to inform the
development of E. coli vaccines [6].
In the UK, the incidence ofE. coliBSI is increasing year on
year (https://www.gov.uk), while E. coli remains the most
common cause of UTI [7]. Therefore, a successful ExPEC
vaccine has the potential to reduce the incidence of BSI and
UTI attributable to dominant strains in the UK and around the
world [8–10].
Over time a number of associations between serotypes, STs,
and E. coli pathotypes have been observed, such as ExPEC
O25b:H4 (ST131), enterohaemorrhagic E. coli (EHEC)
O157:H7 (ST11), EHEC O104:H4 (ST678), and avian patho-
genic E. coli (APEC) O1 (ST95) [11–14]. Serotyping remains
an important method in identifying clinically-significant
ExPEC strains and for the study of local ExPEC populations
in laboratories lacking molecular capability [4]. However, few
UK studies of ExPEC have evaluated the importance of sero-
type in relation to ST, phylogroup, and infection type [1–3, 15].
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Therefore, we resolved to understand the relevance of
serogroup within the UK ExPEC population and identify im-
portant links with infection type and sequence type.
Materials and methods
Bacterial strains
The 658 UK ExPEC isolates studied were part of a larger
collection described previously [16]. They comprised 379 uri-
nary isolates collected predominantly from patients in East
London (Barts Health NHS Trust) and 279 bloodstream iso-
lates collected as part of the BSAC Bacteraemia Resistance
Surveillance Programme (2011). This included isolates from
38 centres located around the UK and Republic of Ireland
[17]. The purpose of these two collections was to identify
any common trends among ExPEC isolates recovered from
urine versus isolates recovered from BSI.
The urinary isolates were recovered from episodes of com-
plicated (n = 170, 45 %) and uncomplicated UTI (n = 161,
42 %), as well as cases of asymptomatic bacteruria (n = 48,
13 %). For bloodstream isolates, the presumed focus of BSI
was genitourinary (n = 118, 42 %), gastrointestinal (n = 38,
14 %), chest (n = 14, 5 %), catheter-related line (n = 4, 1 %)
or skin and soft-tissue infection (n = 2, <1 %), with the prima-
ry source unknown in 37 % (n = 103).
Phenotypic serogrouping, phylogrouping and sequence
typing PCR
Conventional serogrouping was performed using the method
of Gross and Rowe [18]. Phylogroup was determined by PCR
[19]. The major ExPEC STs (ST131, ST95, ST73 and ST69)
were also identified by PCR [20], along with an additional
p r imer pa i r to de tec t ST127 . The forward (5 ′ -
CGCATAACAGGATTGTCTGG-3′) and reverse (5′-
GCTATTCTACGGGCATTGTG-3′) primers for ST127 gen-
erated an amplicon of 404 bp.
Results
Regional distribution
The majority of study isolates (n = 445, 68 %) were collected
in London (379 urinary and 66 bloodstream). Outside of
London between four (South–East) and 34 (Yorkshire and
Humber) bloodstream isolates were collected from each
Public Health England (PHE) Surveillance region. In total,
203 (73 %) bloodstream isolates were collected from
England, 21 (8 %) from Wales, 23 (8 %) from Scotland and
32 (11 %) from the Republic of Ireland. Patient demographics
of the isolates studied are detailed in Table 1.
By region and country the same three serogroups dominat-
ed: O2, O6, and O25. It is noteworthy that O25 was identified
most frequently, except in the North–East and East Midlands
regions where serogroup O6 was the most common. In Wales
this differed slightly, with O25 being the most common,
followed by O16 and O75.
Phylogroup B2 was dominant in each country, accounting
for 62–90 % of isolates, and was also the most prevalent
phylogroup in each PHE region. It is noteworthy that B2
was the only phylogroup detected within the South–East and
West Midlands, together with ST131 which was the only ma-
jor ExPEC ST detected in these regions. ST131 also dominat-
ed in each country, except for Ireland where ST95 was mar-
ginally more prevalent. In addition to ST131, ST73 was the
only other major ST detected in Welsh isolates. Similarly,
Scottish isolates comprised mostly ST131, ST73, and also
ST127. The dominant ST varied by PHE region between
ST131 (East, Yorkshire & Humber, West Midlands, and the
South), ST73 (North–East), ST95 (North–West and London)
and ST127 (East Midlands).
Relationship of serogroup to infection site
There was greater serogroup diversity among the urinary iso-
lates than the bloodstream isolates. Of the 62 serogroups iden-
tified, 54 were found in the urinary and 35 among the blood-
stream isolates. Twenty-seven serogroups were specific to UTI,
and eight were specific to bloodstream infections (Fig. 1).
Table 1 Patient characteristics
for all the study isolates Urinary isolates (%) Bloodstream isolates (%)
Sex Female 312 (82) 149 (53)
Male 67 (18) 130 (47)
Age (years) Range 1–99 0–97
Median 39 73
Healthcare setting Community-associated 337 (89) 190 (68)
Hospital-associated 42 (11) 89 (32)
Total 379 279
The number of isolates is listed for each category, with the percentage in parenthesis
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The proportion of isolates comprising the most prevalent
serogroups (O2, O6, and O25) differed by infection type.
Twenty-nine percent (n = 110/379) of urinary isolates com-
prised these serogroups, with O6 the most commonly identi-
fied, followed by O25. This pattern was reversed in the 43 %
of bloodstream isolates comprising these three serogroups
(n = 120/279), with O25 the most commonly identified,
followed by O6.
Antibiotic susceptibility data was performed as part of a
previous study [16] and was reviewed for these three
serogroups. Serogroup O25 was the most resistant of the three
serogroups, followed by O2. Notably, BSI isolates within
serogroups O6 and O25 were more resistant than the urinary
isolates, but for O2 isolates this was reversed and the urinary
isolates were more resistant than those from BSI.
Relationship of serogroup to phylogroup
Phylogroups A, B1, B2, and D comprised 31, 10, 31, and 22
different serogroups respectively (Fig. 1). It is noteworthy that
19 serogroups were only detected in phylogroups A and B1,
while 27 serogroups were only detected in phylogroups B2
and D (Fig. 1). Within all four phylogroups, the urinary iso-
lates displayed a greater variety of serogroups than BSI iso-
lates. However, in phylogroups B2 and D an even greater
number of serogroups were identified in both infection types.
The most common serogroups in each of the phylogroups
were O8 (A and B1), O25 (B2), and O44 (D).
Relationship between phylogroup and ST
The phylogroup and ST of the isolates studied are detailed in
Table 2. ST131, ST95, and ST73 were only detected in
phylogroups B2 and D, while ST69 was detected among all
phylogroups except A, and ST127 was detected in
phylogroups A and B2.With the exception of ST131, all other
STs were identified more frequently in urinary isolates than
BSI isolates.
One isolate was not assigned a phylogroup or a major
ExPEC ST, but was identified as having serogroup O18ab.
A
O3 O5 O12 O20 O28ac O29
O40 O62 O78 O87 O93 O101
O118 O141 O162
B1
O37 O103
B2
O4  O16 O 18ac O19a O39 O75 
O77 O81 O83 O84 O110
O119 O120 O136 O158
D
O17 O32 O56 O73
O102 O125ab
O36 O46
O134
O2 O22 O31 
O44 O117 
O153
O11 O45 
O135 O150
Multiple
O1 O7 O8 
O15 O25 
O27 O86
A & B2
O6 O18ab
O21
B1 & D
O182
Fig. 1 Serogroups identified in
each of the four E. coli
phylogroups. ‘Multiple’ lists the
serogroups identified in three or
four of the phylogroups. Only
O86 was identified in all four
phylogroups. Serogroups only
identified in urinary isolates are
coloured blue, serogroups only
identified in bloodstream isolates
are coloured red and serogroups
identified in both are in bold. The
most common serogroup in each
of the phylogroups was O8 (A
and B1), O25 (B2) and O44 (D)
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Relationship of serogroup to ST
The major ExPEC STs demonstrated reduced serogroup di-
versity, with just 29 of the 62 serogroups identified, as detailed
in Table 3. ST131 and ST127 displayed least serogroup diver-
sity (n = 5 each), while ST69 displayed the greatest diversity
of serogroups (n = 15). With regard to infection type, both
ST131 and ST73 had greater serogroup diversity within their
BSI isolates than urinary isolates, whereas this pattern was
reversed for ST95 and ST69, while ST127 isolates had equal
distribution of serogroups within both infection types. Five
serogroups were only identified in the major ExPEC STs:
O17, O19a, O110, O125ab, and O136. Within the three most
prevalent serogroups; ST95 comprised the majority of O2
isolates (n = 25/44, 57 %), and ST73 comprised more than
half the O6 isolates (n = 42/75, 56 %), followed by ST127
(n = 21/75, 28 %). ST131 comprised the vast majority of
O25 isolates (n = 89/104, 86 %).
Discussion
This is the first large-scale UK study reporting on the
serogroup diversity of E. coli causing UTI and BSI and the
relationship between serogroup, phylogroup, and major
ExPEC STs. Urinary isolates demonstrated greater serogroup
diversity than bloodstream isolates, representing the ability of
many E. coli strains to invade the bladder, but with fewer able
to invade the bloodstream successfully [8]. Similarly, the less
pathogenic phylogroups A and B1 comprised mostly urinary
isolates, with 15 of the 19 phylogroup-specific serogroups
(79 %) detected, while a smaller proportion of phylogroup-
specific serogroups (n = 16/27, 59%)were detected within the
virulent phylogroups B2 and D bloodstream isolates.
In keeping with this pattern, the major ExPEC STs com-
prised mostly phylogroup B2 and D isolates, and displayed a
limited repertoire of serogroups. This was notable for ST131/
B2 (O25) and ST73/B2 (O6) which were prevalent among
bloodstream isolates, while ST95/B2 (O2) and ST69/D
(O77) were most frequently identified in urinary isolates.
The link between phylogroup and major ExPEC ST is well
established [21–23], but data from this study highlights that
the relationship between serogroup and ST is just as impor-
tant, as evidenced by the dominant serogroups found: ST131-
O25 (B2), ST73-O6 (B2), and ST95-O2 (B2). This important
link between serogroup and ST may have developed either
through clonal expansion (ST131-O25) [13] or due to
virulence-associated traits (ST127-O6 and ST73-O6) [24],
but either way, identification of serogroup in E. coli isolates
provides an alternative means to identify major ExPEC clones
and understand the local ExPEC population.
While the serogroup repertoire for the major UK ExPEC
STs may be limited, it appears to be changing when compared
to previously published reports [1, 25]. This could represent
the large sample size examined here or the fact that the UK
ExPEC STs have evolved. Away from the major known STs,
analysis of this UK collection identified 21 serogroups not
previously documented among ExPEC isolates, again
highlighting a limitation of studies that have focused on small
populations or referred strain collections. These newly identi-
fied ExPEC serogroups included O12, O31, O32, O36, O37,
O39, O40, O46, O56, O62, O81, O83, O87, O93, O110,
O118, O135, O150, O158, O162, and O182 [4, 26, 27].
These novel ExPEC serogroups highlight the importance of
fully understanding the local ExPEC population, clonal or
otherwise, for future vaccine development, for genotypic
Table 2 ExPEC phylogroup and sequence type for all study isolates
Urinary isolates (%) Bloodstream isolates (%)
Phylogroup A 54 (14) 22 (8)
B1 24 (6) 7 (3)
B2 215 (57) 202 (72)
D 86 (23) 47 (17)
NK 0 1 (<1)
Major ST ST131 41 (11) 74 (27)
ST127 16 (4) 12 (4)
ST95 56 (15) 34 (12)
ST73 40 (11) 39 (14)
ST69 50 (13) 14 (5)
Other 176 (46) 106 (38)
Table 3 Serogroups identified in the major ExPEC sequence types by infection type
ST131 ST127 ST95 ST73 ST69
Urinary O16 O25 O1 O6 O31 O110 O150 O153 O4 O158 O17 O45 O73 O102 O117 O150 O153
Bloodstream O19a O136 O153 O11 O27 O8 O18ac O27 O27 O125ab
Both O16 O25 O6 O2 O4 O16 O18ac O2 O6 O22 O25 O11 O15 O25 O44 O77 O86
Serogroups in bold text comprised >50 % of all isolates in that ST and the most common serogroups are underlined
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laboratory tests targeting this particular microbial population,
and to further understand the clinical importance and viru-
lence of emerging strains of E. coli and the diseases they
cause.
To conclude, this large study detailed the serogroup diver-
sity of ExPEC isolates causing UTI and BSI in the UK, with
particular reference to major STs. Data collected here can be
used to expand our knowledge of ExPEC, as well as to inform
vaccine development.
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